Jylamvo
Payments companies reported to CMS as associated with Jylamvo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Jylamvo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Jylamvo
These are the largest totals companies reported as associated with Jylamvo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Tony Philip | New Hyde Park, NY | Hematology & Oncology | $4,950.00 |
| Michael Grunwald | Charlotte, NC | Hematology (Internal Medicine) | $4,950.00 |
| Seetal Mewar | Lake Worth, FL | Hematology & Oncology | $3,850.00 |
| Anna Lefebvre | Boston, MA | Pediatrics (Nurse Practitioner) | $1,459.00 |
| Neha Pansuria | Bowling Green, KY | Rheumatology | $64.17 |
| Dedri Ivory | Vicksburg, MS | Rheumatology | $45.43 |
| Barbara Phelps | Jackson, MS | Family | $45.43 |
| Lisa Proffitt | Glasgow, KY | Family | $38.37 |
| Ian Orozco | Gallipolis, OH | Endocrinology, Diabetes & Metabolism | $34.09 |
| Michael Darley | Provo, UT | Rheumatology | $34.09 |
Prescribed Jylamvo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.